Earnings Call · Q2 FY2024·2024-07-30

Q2 24EPS +27.14%·Rev n/aQ1 24EPS 0.00%·Rev n/aQ4 23EPS +2.30%·Rev n/aQ3 23EPS -7.69%·Rev n/a⚠ consensus missing

Pacira BioSciences, Inc. PCRX

Susan Mesco — Head of Investor Relations

Frank Lee — Chief Executive Officer

Tony Molloy — Chief Legal Counsel

Charles Reinhart — Chief Financial Officer

+5.7%1d on move date+4.1% vs SPY3d+8.8%5d+10.6%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more PCRX calls or request research access.

More PCRX calls Browse calls Request research access